David Ewing Duncan is an award-winning journalist in print, television, and radio; the best-selling author of ten books published in 21 languages; and an entrepreneur. His most recent book is Talking to Robots: Tales from our Human-Robot Futures (Dutton). David recently wrote a series on COVID-19 for Vanity Fair, which has been seen by millions of readers. David is CEO of Arc Fusion, and a frequent contributor to Vanity Fair, Wired, MIT Technology Review, The New York Times, Atlantic, and others. He is a former commentator for NPR's Morning Edition, and a special correspondent and producer for ABC’s Nightline. He is the founding director, Center of Life Science Policy at UC Berkeley. His books include When I'm 164: The New Science of Radical Life Extension, and What Happens If It Succeeds (Ted books), Experimental Man: What One Man's Body Reveals about His Future, Your Health, and Our Toxic World (Wiley), and global bestseller Calendar: Humanity’s epic struggle to determine a true and accurate year (HarperCollins). He is a former special health advisor to IDEO. David is finishing a book he is co-authoring with Craig Venter called The Secret Lives of Earth’s Smallest Creatures: Exploring the Microbiome that Connects Everything, due out with Little Brown and Harvard University Press in 2021. His first novel, a biomedical thriller. David’s awards include Magazine Story of the Year from AAAS and nominations for two National Magazine Awards. He has served on special communications committees at the National Academies of Science and is on the faculty of Singularity University. He lives in Boston and San Francisco and is a member of the San Francisco Writer’s Grotto.